The recent exponential increase in the number of COVID-19 patients in Italy led to the adoption of specific extraordinary measures, such as the need to convey treatment of all non-deferrable cancer patients to specialized centres (hubs). We reported a comprehensive summary of guidelines to create and run an oncologic hub during the COVID-19 pandemic. Oncologic hubs must fulfil some specific requirements such as a high experience in oncologic patient treatment, strict strategies applied to remain a “COVID-19-free” centre, and the creation of a dedicated multidisciplinary “hub team”. Cancer treatment of patients who belong to external centres, namely spoke centres, could be organized in different pathways according to the grade of involvement and/or availability of the medical team of the spoke centre. Moreover, dedicated areas should be created for the management and treatment of patients who developed COVID-19 symptoms after hospitalization (i.e., dedicated wards, operation rooms and intensive care beds). Lastly, hospital staff must be highly trained for both preventing COVID-19 contagion and treating patients who develop the infection. We provided a simplified, but complete and easily applicable guide. We believe that this guide could help those clinicians who have to treat oncologic patients during the COVID-19 pandemic.

A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients / F.A. Mistretta, S. Luzzago, L.O. Molendini, M. Ferro, E. Dossena, F. Mastrilli, G. Musi, O. de Cobelli. - In: CANCERS. - ISSN 2072-6694. - 12:6(2020 Jun), pp. 1513.1-1513.11. [10.3390/cancers12061513]

A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients

F.A. Mistretta
Primo
;
S. Luzzago
Secondo
;
L.O. Molendini;G. Musi
Penultimo
;
O. de Cobelli
Ultimo
2020

Abstract

The recent exponential increase in the number of COVID-19 patients in Italy led to the adoption of specific extraordinary measures, such as the need to convey treatment of all non-deferrable cancer patients to specialized centres (hubs). We reported a comprehensive summary of guidelines to create and run an oncologic hub during the COVID-19 pandemic. Oncologic hubs must fulfil some specific requirements such as a high experience in oncologic patient treatment, strict strategies applied to remain a “COVID-19-free” centre, and the creation of a dedicated multidisciplinary “hub team”. Cancer treatment of patients who belong to external centres, namely spoke centres, could be organized in different pathways according to the grade of involvement and/or availability of the medical team of the spoke centre. Moreover, dedicated areas should be created for the management and treatment of patients who developed COVID-19 symptoms after hospitalization (i.e., dedicated wards, operation rooms and intensive care beds). Lastly, hospital staff must be highly trained for both preventing COVID-19 contagion and treating patients who develop the infection. We provided a simplified, but complete and easily applicable guide. We believe that this guide could help those clinicians who have to treat oncologic patients during the COVID-19 pandemic.
No
English
COVID-19; Medical oncology; Oncology service; SARS-CoV-2; Surgical oncology
Settore MED/24 - Urologia
Nota o Commento
Esperti anonimi
Pubblicazione scientifica
giu-2020
MDPI AG
12
6
1513
1
11
11
Pubblicato
Periodico con rilevanza internazionale
scopus
pubmed
crossref
wos
datacite
Aderisco
info:eu-repo/semantics/article
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients / F.A. Mistretta, S. Luzzago, L.O. Molendini, M. Ferro, E. Dossena, F. Mastrilli, G. Musi, O. de Cobelli. - In: CANCERS. - ISSN 2072-6694. - 12:6(2020 Jun), pp. 1513.1-1513.11. [10.3390/cancers12061513]
open
Prodotti della ricerca::01 - Articolo su periodico
8
262
Article (author)
no
F.A. Mistretta, S. Luzzago, L.O. Molendini, M. Ferro, E. Dossena, F. Mastrilli, G. Musi, O. de Cobelli
File in questo prodotto:
File Dimensione Formato  
A Guide for Oncologic.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.57 MB
Formato Adobe PDF
1.57 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/821994
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact